RESOURCE CORE 2 - BIOLOGICAL STUDIES CORE
RESOURCE CORE 2 - BIOLOGICAL STUDIES CORE
批准号:
8205992
负责人:
Virginia Kraus
金额:
$15.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-09-15 至
关键词:
AddressAgeAgingAmericanAmino AcidsAnimalsArthritisBiochemicalBiochemical MarkersBiochemical ProcessBiologicalBiological AgingBiological AssayBiological MarkersCarnitineCellsCellular AssayChinese PeopleClinicalClinical ResearchClinical TrialsCohort StudiesCommunitiesCore FacilityCounselingCross-Sectional StudiesDataDatabasesDevelopmentDiseaseEarly identificationElderlyExerciseFunctional disorderFundingGenetic MarkersGlycineGoalsGrantHealthHealth ProfessionalHumanIndividualInstructionInsulin ResistanceInterventionKnowledgeLeadLipidsLongevityMaintenanceMeasuresMediator of activation proteinMetabolicMetabolic MarkerMetabolismMethodsMitochondriaModificationMolecularMolecular ProfilingMorbidity - disease rateMuscle MitochondriaPathway interactionsPhysical FunctionProcessPublicationsResearchResourcesRiskRisk FactorsSamplingSupplementationTestingTimeTissuesTrainingTranslatingUrineWorkadductage relatedbaseclinically relevantcohortcollaboratorycombatfitnessfunctional declinefunctional outcomesfunctional statusinsightinvestigator traininglaboratory facilitymetabolomicsmortalitynovel markernovel strategiesprognosticprogramstherapy designtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Biological Studies Core (RC2) facility is to provide a centralized resource for biomarker analyses in support of Duke Pepper OAIC projects to evaluate biomarker profiles as mediators and predictors of function and functional decline. This Core will provide a comprehensive laboratory facility for assays of cellular, molecular, biochemical and metabolomic factors related to aging and functional decline, inflammation and joint tissue metabolism.. The proposed Core Facility will serve in these capacities and will provide biomarker analyses to three large new externally funded studies in human cohorts to validate associations, discovered through the Duke Pepper OAIC in the previous 5 years, of physical function and functional decline with biomarkers, and to expand, enhance and refine knowledge related to these biomarkers as potential mediators and predictors of function. These three cohorts will afford the opportunity to: 1) assess the strength of the prognostic capability of the biomarkers for predicting risk of functional decline or mortality over the subsequent 1-3 years; 2) assess concurrent change in biomarkers and function in a community sample with acquisition of baseline and 24-month longitudinal samples; 3) assess both concurrent change in biomarkers and functional status and the impact of an exercise intervention on biochemical and metabolic markers as well as physical function. The Core Facility will also initially support
one Developmental Project to advance the understanding of metabolic function and aging. This project will focus on developing a targeted mass spectroscopic analytic method for acylglycines in urine and will evaluate concurrent change in this new marker and metabolic health and insulin resistance with a clinical trial intervention of glycine supplementation in animals. This Core will also continue to serve as a resource for the training of investigators on principles and methods of biomarker analyses. These biomarker studies are expected to provide further insights into the molecular pathophysiology of aging to inform potential new strategies for intervention and modification of functional decline. The overall approach will continue to be one of a 'Collaboratory' in which multiple excellent clinical studies will contribute subsets of samples for biomarker analyses by the Duke Pepper OAIC Biological Studies Core, and statistical analysis of results by the Duke Pepper OAIC Analysis Core, to address, jointly and severally, the overarching Duke Pepper OAIC theme of exploring approaches to understand and modify multiple pathways of functional decline, and to translate noteworthy findings into disseminated knowledge through publications and advances in health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular Vesicle Analyses to Develop Aging and Resilience Biomarkers
-
批准号:10318917
-
项目类别:
-
资助金额:$64.65万
-
财政年份:2021
-
负责人:Virginia Kraus
-
依托单位:
Extracellular Vesicle Analyses to Develop Aging and Resilience Biomarkers
-
批准号:10550122
-
项目类别:
-
资助金额:$60.63万
-
财政年份:2021
-
负责人:Virginia Kraus
-
依托单位:
Epigenetic Mechanisms Promoting Longevity
-
批准号:10180813
-
项目类别:
-
资助金额:$65.91万
-
财政年份:2018
-
负责人:Virginia Kraus
-
依托单位:
Epigenetic Mechanisms Promoting Longevity
-
批准号:10434680
-
项目类别:
-
资助金额:$65.76万
-
财政年份:2018
-
负责人:Virginia Kraus
-
依托单位:
Epigenetic Mechanisms Promoting Longevity
-
批准号:9551744
-
项目类别:
-
资助金额:$51.51万
-
财政年份:2017
-
负责人:Virginia Kraus
-
依托单位:
Qualification of Prognostic and Diagnostic Biomarkers of Knee Osteoarthritis
-
批准号:9289779
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2017
-
负责人:Virginia Kraus
-
依托单位:
Development of Methods to Quantify Biological and Pathological Aging of Cartilage
-
批准号:8094579
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2011
-
负责人:Virginia Kraus
-
依托单位:
Development of Methods to Quantify Biological and Pathological Aging of Cartilage
-
批准号:8321475
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2011
-
负责人:Virginia Kraus
-
依托单位:
Core B
-
批准号:7503719
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2007
-
负责人:Virginia Kraus
-
依托单位:
Research Core 1: Molecular Measures Core (RC1)
-
批准号:10670271
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2006
-
负责人:Virginia Kraus
-
依托单位:
Research Core 1: Molecular Measures Core (RC1)
-
批准号:10291438
-
项目类别:
-
资助金额:$21.91万
-
财政年份:2006
-
负责人:Virginia Kraus
-
依托单位:
STRATEGIES TO PREDICT OSTEOARTHRITIS PROGRESSION
-
批准号:7198469
-
项目类别:
-
资助金额:$6.07万
-
财政年份:2005
-
负责人:Virginia Kraus
-
依托单位:
GOGO
-
批准号:7198449
-
项目类别:
-
资助金额:$12.71万
-
财政年份:2005
-
负责人:Virginia Kraus
-
依托单位:
Genetics of Generalized Osteoarthritis (GOGO)
-
批准号:6974008
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2004
-
负责人:Virginia Kraus
-
依托单位:
Strategies to Predict Osteoarthritis Progression
-
批准号:6974037
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2004
-
负责人:Virginia Kraus
-
依托单位:
Biomarkers Core
-
批准号:8131693
-
项目类别:
-
资助金额:$12.84万
-
财政年份:2003
-
负责人:Virginia Kraus
-
依托单位:
Determination of OA Pathology by Biomarker Dating
-
批准号:7123081
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2003
-
负责人:Virginia Kraus
-
依托单位:
Determination of OA Pathology by Biomarker Dating
-
批准号:7283089
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2003
-
负责人:Virginia Kraus
-
依托单位:
Determination of OA Pathology by Biomarker Dating
-
批准号:6947351
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2003
-
负责人:Virginia Kraus
-
依托单位:
Determination of OA Pathology by Biomarker Dating
-
批准号:6743494
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2003
-
负责人:Virginia Kraus
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: